Oak Associates’s Humana HUM Stock Holding History

Oak Associates’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,883	Closed	-$1.82M	–	131
2024 Q2	$1.82M	Hold	4,883	–	–	0.12%	85
2024 Q1	$1.69M	Hold	4,883	–	–	0.12%	88
2023 Q4	$2.24M	Buy	4,883 +303	+7%	+$149K	0.17%	73
2023 Q3	$2.23M	Buy	4,580 +850	+23%	+$399K	0.19%	66
2023 Q2	$1.67M	Hold	3,730	–	–	0.13%	86
2023 Q1	$1.81M	Hold	3,730	–	–	0.15%	85
2022 Q4	$1.91M	Buy	3,730 +600	+19%	+$315K	0.16%	87
2022 Q3	$1.52M	Hold	3,130	–	–	0.13%	87
2022 Q2	$1.47M	Hold	3,130	–	–	0.11%	86
2022 Q1	$1.36M	Hold	3,130	–	–	0.08%	96
2021 Q4	$1.45M	Hold	3,130	–	–	0.08%	96
2021 Q3	$1.22M	Hold	3,130	–	–	0.07%	95
2021 Q2	$1.39M	Hold	3,130	–	–	0.08%	92
2021 Q1	$1.31M	Buy	+3,130	New	+$1.25M	0.08%	93

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Oak Associates's HUM Position: Q3 2024 in Review

Oak Associates sold out of Humana (HUM) in Q3 2024, closing a stake of 4,883 shares — an estimated $1.82M sold.

Oak Associates first reported a position in HUM in Q1 2021 and held it in 14 quarters. The position peaked at $2.24M in Q4 2023. 941 funds tracked by Wall St. Rank hold HUM as of Q3 2024.

Oak Associates reported no remaining Humana position as of Q3 2024 after selling out during the quarter.
Oak Associates sold 4,883 Humana shares in Q3 2024, an estimated $1.82M.
Oak Associates first reported a position in Humana in Q1 2021 and held it in 14 quarters.
Oak Associates's Humana position peaked at $2.24M in Q4 2023.
941 funds tracked by Wall St. Rank held Humana as of Q3 2024.

Based on Oak Associates's 13F filing for Q3 2024, filed 12 Nov 2024.